GRAS Notice 740 for Glycolipids from Dacryopinax Spathularia

Total Page:16

File Type:pdf, Size:1020Kb

GRAS Notice 740 for Glycolipids from Dacryopinax Spathularia GRAS Notice (GRN) No. 740 https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/NoticeInventory/default.htm l:•:.. •••••• TRS TOXICOLOGY REGULATORY SERVICES 26 October 2017 via UPS Paulette M. Gaynor, Ph.D. Senior Regulatory Health Project Manager Division of Biotechnology and GRAS Notice Review Office of Food Additive Safety (HFS-200) Center for Food Safety and Applied Nutrition Food and Drug Administration 500 1 Campus Drive College Park, MD 20740 Re: GRAS Notification for Long-Chain Glycolipids from Dacryopinax spathularia Dear Dr. Gaynor, In accordance with 21 CFR §170, Subpart E - Generally Recognized as Safe (GRAS) Notice, I am submitting, as the agent of the Notifier, IMD Natural Solutions GmbH, Otto-Hahn-Str. 15, 44227 Dortmund, Germany, a Notification regarding the conclusion of GRAS status for the use of long-chain glycolipids from Dacryopinax spathularia as an antimicrobial preservative in select non-alcoholic beverages. Enclosed is one printed copy of the Notification as well as an electronic copy of the Notification on CD. Please contact me with any questions. Best regards, (b) (6) lRi~~~G~\E\D) Andrey I. Nikiforov, Ph.D. OCT 3 0 2017 President OFFICE OF FOOD ADDITIVE SAFETY AIN/mor Enclosures 154 Hansen Road, Suite 201, Charlottesville, VA 22911, USA Telephone: +l 434-977-5957 • Facsimile: +1 434-977-1856 • [email protected] • www.toxregserv.com SAFETY EVALUATION DOSSIER SUPPORTING A GENERALLY RECOGNIZED AS SAFE (GRAS) CONCLUSION FOR THE USE OF LONG-CHAIN GLYCOLIPIDS FROM DACRYOPINAXSPATHULARIA IN NON-ALCOHOLIC BEVERAGES SUBMITTED BY: IMO Natural Solutions GmbH Otto-Hahn-Str. 15 44227 Dortmund, Germany SUBMITTED TO: U.S. Food and Drug Administration Center for Food Safety and Applied Nutrition Office of Food Additive Safety (HFS-200) 5001 Campus Drive College Park, MD 20740 CONTACT FOR TECHNICAL OR OTHER INFORMATION: Andrey I. Nikiforov, Ph.D. Toxicology Regulatory Services (TRS), Inc. 154 Hansen Road, Suite 201 Charlottesville, VA 22911, U.S.A. October 26, 201 7 fR1~~~IlYJ~lQ) OCT 3 0 20l7 OFFICE OF FOOD ADDITIVE SAFETY Table of Contents Part 1. SIGNED STATEMENTS AND CERTIFICATION...........................................................1 A. Name and Address of Notifier .....................................................................................1 B. Name of GRAS Substance ...........................................................................................1 C. Intended Use and Consumer Exposure ........................................................................2 D. Basis for GRAS Conclusion ........................................................................................2 E. Availability of Information ..........................................................................................3 Part 2. IDENTITY, METHOD OF MANUFACTURE, SPECIFICATIONS, AND PHYSICAL OR TECHNICAL EFFECT ...................................................................4 A. Identity ..........................................................................................................................4 B. Production Process .......................................................................................................5 C. Product Characteristics .................................................................................................7 D. Physical or Technical Effect ......................................................................................10 Part 3. DIETARY EXPOSURE ...................................................................................................11 A. Intended Uses and Use Levels ....................................................................................11 B. Estimated Daily Intake (EDI) of Jelly Mushroom Glycolipids..................................11 Part 4. SELF- LIMITING LEVELS OF USE ................................................................................15 Part 5. EXPERIENCE BASED ON COMMON USE IN FOOD BEFORE 1958 .......................16 Part 6. BASIS FOR CONCLUSION OF GRAS STATUS FOR JELLY MUSHROOM GLYCOLIPIDS AM-1 (NARRATIVE) ...........................................................................17 Introduction ........................................................................................................................17 Historical Consumption .....................................................................................................18 Safety Assessment of Jelly Mushroom Glycolipids Production Organism .......................18 Absorption, Distribution, Metabolism and Excretion (ADME) Profile of Jelly Mushroom Glycolipids (AM-1) ......................................................................................21 Toxicology Profile of Jelly Mushroom Glycolipids (AM-1) .............................................32 Acute Toxicity, Irritation, and Sensitization Studies with Jelly Mushroom Glycolipids ................................................................................................................32 Assessment of Mutagenicity and Carcinogenicity Potential for Jelly Mushroom Glycolipids ................................................................................................................34 Genotoxicity Studies with Jelly Mushroom Glycolipids ..............................................35 Subchronic (Repeated Dose) Toxicity Studies with Jelly Mushroom Glycolipids ................................................................................................................36 Assessment of Reproductive and Developmental Toxicity Potential for Jelly Mushroom Glycolipids ..............................................................................................40 Rat Developmental Toxicity Study with Jelly Mushroom Glycolipids .........................40 Rat Two-Generation Reproduction Toxicity Study with Jelly Mushroom Glycolipids ................................................................................................................42 Safety Assessment of Jelly Mushroom Glycolipids Minor Component ............................45 Summary and Discussion of ADME and Toxicology Database for Jelly Mushroom Glycolipids ......................................................................................................................48 GRAS NOTIFICATION FOR JELLY MUSHROOM GLYCOLIPIDS (AM-1) i October 26, 2017 Part 6. BASIS FOR CONCLUSION OF GRAS STATUS FOR JELLY MUSHROOM GLYCOLIPIDS AM-1 (NARRATIVE) - continued Allergenicity ......................................................................................................................48 Summary of Safety Assessment and GRAS Conclusion ...................................................50 Acceptable Daily Intake (ADI) for Jelly Mushroom Glycolipids (AM-1) ....................50 Comparison of ADI and EDI for Jelly Mushroom Glycolipids (AM-1) .......................51 General Recognition of the Safety of Jelly Mushroom Glycolipids (AM-1) ................52 Part 7. LIST OF SUPPORTING DATA AND INFORMATION ................................................53 Listing of Figures Figure 1. Representative Structures for Jelly Mushroom Glycolipids (AM-1) ..............................4 Figure 2. Manufacturing Process Flow Diagram for Jelly Mushroom Glycolipids (AM-1) ..........6 Figure 3. Pariza and Johnson (2001) Decision Tree Analysis of Jelly Mushroom Glycolipids (AM-1) Production Organism, Dacryopinax spathularia MUCL 53181 .....................19 Figure 4. Proposed Degradation of Jelly Mushroom Glycolipids (AM-1) to LCFA....................22 Figure 5. Mean Concentration of Test Substance Equivalents in Rat Plasma (µg/g) following Oral Administration of [14C]-AM-1 or [14C]-LCFA .....................................28 Figure 6. Mean Concentration of Test Substance Equivalents in Rat Plasma (µg/g) following IV Administration of [14C]-AM-1 .................................................................29 Figure 7. Mean Concentration of Test Substance Equivalents in Rat Plasma (µg/g) following IV Administration of [14C]-LCFA ................................................................30 Listing of Tables Table 1. Specifications for Jelly Mushroom Glycolipids (AM-1) ..................................................9 Table 2. Proposed Uses and Maximum Use Levels of Jelly Mushroom Glycolipids (AM-1) .....11 Table 3. Estimated Daily Intake of Jelly Mushroom Glycolipids (AM-1) from Proposed Uses at Maximum Use Levels (Total U.S. Population) ................................................13 Table 4. Estimated Daily Intake of Jelly Mushroom Glycolipids (AM-1) from All Proposed Uses (Maximum Use Levels) by Population Subgroup (Infants, Children, Teenagers and Adults) ...................................................................................................13 Table 5. Experimental Design and Group Assignment During a Pharmacokinetics, Excretion Balance, and Tissue Distribution Study of [14C]-AM-1 and [14C]-LCFA in Sprague Dawley Rats ..................................................................................................................23 Table 6. Pharmacokinetics of Test Article Equivalents in Group 1 and Group 2 Rats following an Oral Dose of [14C]-AM-1 at 100 mg/kg or [14C]-LCFA at 46 mg/kg ......................26 Table 7. Pharmacokinetics of Test Article Equivalents in Group 3 and Group 4 Rats following an IV Dose of [14C]-AM-1 at 10 mg/kg or [14C]-LCFA at 4.6 mg/kg ..........................27 Table 8. Acceptable Daily Intake for Jelly Mushroom Glycolipids (AM-1) from Totality-of-Evidence .....................................................................................................51
Recommended publications
  • The 2014 Golden Gate National Parks Bioblitz - Data Management and the Event Species List Achieving a Quality Dataset from a Large Scale Event
    National Park Service U.S. Department of the Interior Natural Resource Stewardship and Science The 2014 Golden Gate National Parks BioBlitz - Data Management and the Event Species List Achieving a Quality Dataset from a Large Scale Event Natural Resource Report NPS/GOGA/NRR—2016/1147 ON THIS PAGE Photograph of BioBlitz participants conducting data entry into iNaturalist. Photograph courtesy of the National Park Service. ON THE COVER Photograph of BioBlitz participants collecting aquatic species data in the Presidio of San Francisco. Photograph courtesy of National Park Service. The 2014 Golden Gate National Parks BioBlitz - Data Management and the Event Species List Achieving a Quality Dataset from a Large Scale Event Natural Resource Report NPS/GOGA/NRR—2016/1147 Elizabeth Edson1, Michelle O’Herron1, Alison Forrestel2, Daniel George3 1Golden Gate Parks Conservancy Building 201 Fort Mason San Francisco, CA 94129 2National Park Service. Golden Gate National Recreation Area Fort Cronkhite, Bldg. 1061 Sausalito, CA 94965 3National Park Service. San Francisco Bay Area Network Inventory & Monitoring Program Manager Fort Cronkhite, Bldg. 1063 Sausalito, CA 94965 March 2016 U.S. Department of the Interior National Park Service Natural Resource Stewardship and Science Fort Collins, Colorado The National Park Service, Natural Resource Stewardship and Science office in Fort Collins, Colorado, publishes a range of reports that address natural resource topics. These reports are of interest and applicability to a broad audience in the National Park Service and others in natural resource management, including scientists, conservation and environmental constituencies, and the public. The Natural Resource Report Series is used to disseminate comprehensive information and analysis about natural resources and related topics concerning lands managed by the National Park Service.
    [Show full text]
  • Sphingolipid Metabolism Diseases ⁎ Thomas Kolter, Konrad Sandhoff
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1758 (2006) 2057–2079 www.elsevier.com/locate/bbamem Review Sphingolipid metabolism diseases ⁎ Thomas Kolter, Konrad Sandhoff Kekulé-Institut für Organische Chemie und Biochemie der Universität, Gerhard-Domagk-Str. 1, D-53121 Bonn, Germany Received 23 December 2005; received in revised form 26 April 2006; accepted 23 May 2006 Available online 14 June 2006 Abstract Human diseases caused by alterations in the metabolism of sphingolipids or glycosphingolipids are mainly disorders of the degradation of these compounds. The sphingolipidoses are a group of monogenic inherited diseases caused by defects in the system of lysosomal sphingolipid degradation, with subsequent accumulation of non-degradable storage material in one or more organs. Most sphingolipidoses are associated with high mortality. Both, the ratio of substrate influx into the lysosomes and the reduced degradative capacity can be addressed by therapeutic approaches. In addition to symptomatic treatments, the current strategies for restoration of the reduced substrate degradation within the lysosome are enzyme replacement therapy (ERT), cell-mediated therapy (CMT) including bone marrow transplantation (BMT) and cell-mediated “cross correction”, gene therapy, and enzyme-enhancement therapy with chemical chaperones. The reduction of substrate influx into the lysosomes can be achieved by substrate reduction therapy. Patients suffering from the attenuated form (type 1) of Gaucher disease and from Fabry disease have been successfully treated with ERT. © 2006 Elsevier B.V. All rights reserved. Keywords: Ceramide; Lysosomal storage disease; Saposin; Sphingolipidose Contents 1. Sphingolipid structure, function and biosynthesis ..........................................2058 1.1.
    [Show full text]
  • Structural Evidence for Adaptive Ligand Binding of Glycolipid Transfer Protein
    doi:10.1016/j.jmb.2005.10.031 J. Mol. Biol. (2006) 355, 224–236 Structural Evidence for Adaptive Ligand Binding of Glycolipid Transfer Protein Tomi T. Airenne†, Heidi Kidron†, Yvonne Nymalm, Matts Nylund Gun West, Peter Mattjus and Tiina A. Salminen* Department of Biochemistry Glycolipids participate in many important cellular processes and they are and Pharmacy, A˚ bo Akademi bound and transferred with high specificity by glycolipid transfer protein University, Tykisto¨katu 6A (GLTP). We have solved three different X-ray structures of bovine GLTP at FIN-20520 Turku, Finland 1.4 A˚ , 1.6 A˚ and 1.8 A˚ resolution, all with a bound fatty acid or glycolipid. The 1.4 A˚ structure resembles the recently characterized apo-form of the human GLTP but the other two structures represent an intermediate conformation of the apo-GLTPs and the human lactosylceramide-bound GLTP structure. These novel structures give insight into the mechanism of lipid binding and how GLTP may conformationally adapt to different lipids. Furthermore, based on the structural comparison of the GLTP structures and the three-dimensional models of the related Podospora anserina HET-C2 and Arabidopsis thaliana accelerated cell death protein, ACD11, we give structural explanations for their specific lipid binding properties. q 2005 Elsevier Ltd. All rights reserved. Keywords: crystal structure; homology modeling; conformational change; *Corresponding author cavity; fluorescence Introduction to the diverse roles of glycolipids in the cell, GLTP could potentially function as a modulator
    [Show full text]
  • Sphingolipids and Cell Signaling: Relationship Between Health and Disease in the Central Nervous System
    Preprints (www.preprints.org) | NOT PEER-REVIEWED | Posted: 6 April 2021 doi:10.20944/preprints202104.0161.v1 Review Sphingolipids and cell signaling: Relationship between health and disease in the central nervous system Andrés Felipe Leal1, Diego A. Suarez1,2, Olga Yaneth Echeverri-Peña1, Sonia Luz Albarracín3, Carlos Javier Alméciga-Díaz1*, Angela Johana Espejo-Mojica1* 1 Institute for the Study of Inborn Errors of Metabolism, Faculty of Science, Pontificia Universidad Javeriana, Bogotá D.C., 110231, Colombia; [email protected] (A.F.L.), [email protected] (D.A.S.), [email protected] (O.Y.E.P.) 2 Faculty of Medicine, Universidad Nacional de Colombia, Bogotá D.C., Colombia; [email protected] (D.A.S.) 3 Nutrition and Biochemistry Department, Faculty of Science, Pontificia Universidad Javeriana, Bogotá D.C., Colombia; [email protected] (S.L.A.) * Correspondence: [email protected]; Tel.: +57-1-3208320 (Ext 4140) (C.J.A-D.). [email protected]; Tel.: +57-1-3208320 (Ext 4099) (A.J.E.M.) Abstract Sphingolipids are lipids derived from an 18-carbons unsaturated amino alcohol, the sphingosine. Ceramide, sphingomyelins, sphingosine-1-phosphates, gangliosides and globosides, are part of this group of lipids that participate in important cellular roles such as structural part of plasmatic and organelle membranes maintaining their function and integrity, cell signaling response, cell growth, cell cycle, cell death, inflammation, cell migration and differentiation, autophagy, angiogenesis, immune system. The metabolism of these lipids involves a broad and complex network of reactions that convert one lipid into others through different specialized enzymes. Impairment of sphingolipids metabolism has been associated with several disorders, from several lysosomal storage diseases, known as sphingolipidoses, to polygenic diseases such as diabetes and Parkinson and Alzheimer diseases.
    [Show full text]
  • Septal Pore Caps in Basidiomycetes Composition and Ultrastructure
    Septal Pore Caps in Basidiomycetes Composition and Ultrastructure Septal Pore Caps in Basidiomycetes Composition and Ultrastructure Septumporie-kappen in Basidiomyceten Samenstelling en Ultrastructuur (met een samenvatting in het Nederlands) Proefschrift ter verkrijging van de graad van doctor aan de Universiteit Utrecht op gezag van de rector magnificus, prof.dr. J.C. Stoof, ingevolge het besluit van het college voor promoties in het openbaar te verdedigen op maandag 17 december 2007 des middags te 16.15 uur door Kenneth Gregory Anthony van Driel geboren op 31 oktober 1975 te Terneuzen Promotoren: Prof. dr. A.J. Verkleij Prof. dr. H.A.B. Wösten Co-promotoren: Dr. T. Boekhout Dr. W.H. Müller voor mijn ouders Cover design by Danny Nooren. Scanning electron micrographs of septal pore caps of Rhizoctonia solani made by Wally Müller. Printed at Ponsen & Looijen b.v., Wageningen, The Netherlands. ISBN 978-90-6464-191-6 CONTENTS Chapter 1 General Introduction 9 Chapter 2 Septal Pore Complex Morphology in the Agaricomycotina 27 (Basidiomycota) with Emphasis on the Cantharellales and Hymenochaetales Chapter 3 Laser Microdissection of Fungal Septa as Visualized by 63 Scanning Electron Microscopy Chapter 4 Enrichment of Perforate Septal Pore Caps from the 79 Basidiomycetous Fungus Rhizoctonia solani by Combined Use of French Press, Isopycnic Centrifugation, and Triton X-100 Chapter 5 SPC18, a Novel Septal Pore Cap Protein of Rhizoctonia 95 solani Residing in Septal Pore Caps and Pore-plugs Chapter 6 Summary and General Discussion 113 Samenvatting 123 Nawoord 129 List of Publications 131 Curriculum vitae 133 Chapter 1 General Introduction Kenneth G.A. van Driel*, Arend F.
    [Show full text]
  • Metabolism of Brain Glycolipid Fatty Acids '': Yasuo Kishimoto and Norman S
    Metabolism of Brain Glycolipid Fatty Acids '': Yasuo Kishimoto and Norman S. Radin, Mental Health Research Institute, University of Michigan, Ann Arbor, Michigan ABSTRACT and sulfatides contain NFA and tIFA, The metabolism of the fatty acid moieties saturated and unsaturated; the gangliosides, of brain cerebrosides, sulfatides, and however, contain only NFA in which there are gangliosides is reviewed and discussed. only traces of unsaturated acids. In the cere- The methodology involved in the isolation t)rosides and sulfatides there are two clusters of the fatty acids is described briefly. It of FA: those around 18 carbons long and those seems clear now that most of these acids around 24 carbons long. In the gangliosides are made by chain elongation of inter- there is only one cluster, centering around 18:0, mediate length fatty acids by addition of with negligible amounts of 22:0 and 24:0. acetate residues. The unsaturated acids Other points of contrast between gangliosides are made by desaturation of the inter- and the other two can be made: the former mediate length acids (palmitic, heptade- occurs primarily in brain gray matter, the canoic, stearic) followed by chain elonga- latter are primarily in white. The former tion. The hydroxy acids are made directly has glucose attached to the ceramide residue, from the corresponding nonhydroxy acids, the latter have galactose. The former has saturated, unsaturated, and odd-numbered. only traces of odd-numbered FA; the latter All the hydroxy acids undergo oxidative can contain considerable amounts of C~ and decarboxylation to yield fatty acids con- C2.~ FA. Further differences, particularly in taining one less carbon atom.
    [Show full text]
  • Notes, Outline and Divergence Times of Basidiomycota
    Fungal Diversity (2019) 99:105–367 https://doi.org/10.1007/s13225-019-00435-4 (0123456789().,-volV)(0123456789().,- volV) Notes, outline and divergence times of Basidiomycota 1,2,3 1,4 3 5 5 Mao-Qiang He • Rui-Lin Zhao • Kevin D. Hyde • Dominik Begerow • Martin Kemler • 6 7 8,9 10 11 Andrey Yurkov • Eric H. C. McKenzie • Olivier Raspe´ • Makoto Kakishima • Santiago Sa´nchez-Ramı´rez • 12 13 14 15 16 Else C. Vellinga • Roy Halling • Viktor Papp • Ivan V. Zmitrovich • Bart Buyck • 8,9 3 17 18 1 Damien Ertz • Nalin N. Wijayawardene • Bao-Kai Cui • Nathan Schoutteten • Xin-Zhan Liu • 19 1 1,3 1 1 1 Tai-Hui Li • Yi-Jian Yao • Xin-Yu Zhu • An-Qi Liu • Guo-Jie Li • Ming-Zhe Zhang • 1 1 20 21,22 23 Zhi-Lin Ling • Bin Cao • Vladimı´r Antonı´n • Teun Boekhout • Bianca Denise Barbosa da Silva • 18 24 25 26 27 Eske De Crop • Cony Decock • Ba´lint Dima • Arun Kumar Dutta • Jack W. Fell • 28 29 30 31 Jo´ zsef Geml • Masoomeh Ghobad-Nejhad • Admir J. Giachini • Tatiana B. Gibertoni • 32 33,34 17 35 Sergio P. Gorjo´ n • Danny Haelewaters • Shuang-Hui He • Brendan P. Hodkinson • 36 37 38 39 40,41 Egon Horak • Tamotsu Hoshino • Alfredo Justo • Young Woon Lim • Nelson Menolli Jr. • 42 43,44 45 46 47 Armin Mesˇic´ • Jean-Marc Moncalvo • Gregory M. Mueller • La´szlo´ G. Nagy • R. Henrik Nilsson • 48 48 49 2 Machiel Noordeloos • Jorinde Nuytinck • Takamichi Orihara • Cheewangkoon Ratchadawan • 50,51 52 53 Mario Rajchenberg • Alexandre G.
    [Show full text]
  • An Annotated Catalogue of the Fungal Biota of the Roztocze Upland Monika KOZŁOWSKA, Wiesław MUŁENKO Marcin ANUSIEWICZ, Magda MAMCZARZ
    An Annotated Catalogue of the Fungal Biota of the Roztocze Upland Fungal Biota of the An Annotated Catalogue of the Monika KOZŁOWSKA, Wiesław MUŁENKO Marcin ANUSIEWICZ, Magda MAMCZARZ An Annotated Catalogue of the Fungal Biota of the Roztocze Upland Richness, Diversity and Distribution MARIA CURIE-SkłODOWSKA UNIVERSITY PRESS POLISH BOTANICAL SOCIETY Grzyby_okladka.indd 6 11.02.2019 14:52:24 An Annotated Catalogue of the Fungal Biota of the Roztocze Upland Richness, Diversity and Distribution Monika KOZŁOWSKA, Wiesław MUŁENKO Marcin ANUSIEWICZ, Magda MAMCZARZ An Annotated Catalogue of the Fungal Biota of the Roztocze Upland Richness, Diversity and Distribution MARIA CURIE-SkłODOWSKA UNIVERSITY PRESS POLISH BOTANICAL SOCIETY LUBLIN 2019 REVIEWER Dr hab. Małgorzata Ruszkiewicz-Michalska COVER DESIN, TYPESETTING Studio Format © Te Authors, 2019 © Maria Curie-Skłodowska University Press, Lublin 2019 ISBN 978-83-227-9164-6 ISBN 978-83-950171-8-6 ISBN 978-83-950171-9-3 (online) PUBLISHER Polish Botanical Society Al. Ujazdowskie 4, 00-478 Warsaw, Poland pbsociety.org.pl Maria Curie-Skłodowska University Press 20-031 Lublin, ul. Idziego Radziszewskiego 11 tel. (81) 537 53 04 wydawnictwo.umcs.eu [email protected] Sales Department tel. / fax (81) 537 53 02 Internet bookshop: wydawnictwo.umcs.eu [email protected] PRINTED IN POLAND, by „Elpil”, ul. Artyleryjska 11, 08-110 Siedlce AUTHOR’S AFFILIATION Department of Botany and Mycology, Maria Curie-Skłodowska University, Lublin Monika Kozłowska, [email protected]; Wiesław
    [Show full text]
  • <I>Ustilaginomycotina
    Persoonia 33, 2014: 41–47 www.ingentaconnect.com/content/nhn/pimj RESEARCH ARTICLE http://dx.doi.org/10.3767/003158514X682313 Moniliellomycetes and Malasseziomycetes, two new classes in Ustilaginomycotina Q.-M. Wang1, B. Theelen2, M. Groenewald2, F.-Y. Bai1,2, T. Boekhout1,2,3,4 Key words Abstract Ustilaginomycotina (Basidiomycota, Fungi) has been reclassified recently based on multiple gene sequence analyses. However, the phylogenetic placement of two yeast-like genera Malassezia and Moniliella in fungi the subphylum remains unclear. Phylogenetic analyses using different algorithms based on the sequences of six molecular phylogeny genes, including the small subunit (18S) ribosomal DNA (rDNA), the large subunit (26S) rDNA D1/D2 domains, smuts the internal transcribed spacer regions (ITS 1 and 2) including 5.8S rDNA, the two subunits of RNA polymerase II taxonomy (RPB1 and RPB2) and the translation elongation factor 1-α (EF1-α), were performed to address their phylogenetic yeasts positions. Our analyses indicated that Malassezia and Moniliella represented two deeply rooted lineages within Ustilaginomycotina and have a sister relationship to both Ustilaginomycetes and Exobasidiomycetes. Those clades are described here as new classes, namely Moniliellomycetes with order Moniliellales, family Moniliellaceae, and genus Moniliella; and Malasseziomycetes with order Malasseziales, family Malasseziaceae, and genus Malasse- zia. Phenotypic differences support this classification suggesting widely different life styles among the mainly plant pathogenic Ustilaginomycotina. Article info Received: 25 October 2013; Accepted: 12 March 2014; Published: 23 May 2014. INTRODUCTION in the Exobasidiomycetes based on molecular phylogenetic analyses of the nuclear ribosomal RNA genes alone or in Basidiomycota (Dikarya, Fungi) contains three main phyloge- combination with protein genes (Begerow et al.
    [Show full text]
  • Biodiversity, Distribution and Morphological Characterization of Mushrooms in Mangrove Forest Regions of Bangladesh
    BIODIVERSITY, DISTRIBUTION AND MORPHOLOGICAL CHARACTERIZATION OF MUSHROOMS IN MANGROVE FOREST REGIONS OF BANGLADESH KALLOL DAS DEPARTMENT OF PLANT PATHOLOGY FACULTY OF AGRICULTURE SHER-E-BANGLA AGRICULTURAL UNIVERSITY DHAKA-1207 JUNE, 2015 BIODIVERSITY, DISTRIBUTION AND MORPHOLOGICAL CHARACTERIZATION OF MUSHROOMS IN MANGROVE FOREST REGIONS OF BANGLADESH BY KALLOL DAS Registration No. 15-06883 A Thesis Submitted to the Faculty of Agriculture, Sher-e-Bangla Agricultural University, Dhaka, In partial fulfillment of the requirements For the degree of MASTER OF SCIENCE IN PLANT PATHOLOGY SEMESTER: JANUARY - JUNE, 2015 APPROVED BY : ---------------------------------- ----------------------------------- ( Mrs. Nasim Akhtar ) (Dr. F. M. Aminuzzaman) Professor Professor Department of Plant Pathology Department of Plant Pathology Sher-e-Bangla Agricultural University Sher-e-Bangla Agricultural University Supervisor Co-Supervisor ----------------------------------------- (Dr. Md. Belal Hossain) Chairman Examination Committee Department of Plant Pathology Sher-e-Bangla Agricultural University, Dhaka Department of Plant Pathology Fax: +88029112649 Sher- e - Bangla Agricultural University Web site: www.sau.edu.bd Dhaka- 1207 , Bangladesh CERTIFICATE This is to certify that the thesis entitled, “BIODIVERSITY, DISTRIBUTION AND MORPHOLOGICAL CHARACTERIZATION OF MUSHROOMS IN MANGROVE FOREST REGIONS OF BANGLADESH’’ submitted to the Department of Plant Pathology, Faculty of Agriculture, Sher-e-Bangla Agricultural University, Dhaka, in the partial fulfillment of the requirements for the degree of MASTER OF SCIENCE (M. S.) IN PLANT PATHOLOGY, embodies the result of a piece of bonafide research work carried out by KALLOL DAS bearing Registration No. 15-06883 under my supervision and guidance. No part of the thesis has been submitted for any other degree or diploma. I further certify that such help or source of information, as has been availed of during the course of this investigation has duly been acknowledged.
    [Show full text]
  • Austro-American Lignocellulolytic Basidiomycetes (Agaricomycotina): New Records
    ISSN (print) 0093-4666 © 2010. Mycotaxon, Ltd. ISSN (online) 2154-8889 MYCOTAXON doi: 10.5248/114.377 Volume 114, pp. 377–393 October–December 2010 Austro-American lignocellulolytic basidiomycetes (Agaricomycotina): new records Marisa de Campos-Santana & Clarice Loguercio-Leite [email protected] Universidade Federal de Santa Catarina, Laboratório de Micologia BOT/CCB/UFSC, 88090400, Florianópolis, SC, Brazil Abstract — A survey of lignolytic basidiomycetes from Mondaí (27º06’16”S, 53º24’07”W) in the Brazilian state of Santa Catarina has revealed nine previously unrecorded species: Dacryopinax elegans, Cotylidia aurantiaca, Hymenochaete rubiginosa, Inonotus rickii, Phellinus rhytiphloeus, Echinoporia aculeifera, Oxyporus obducens, Amauroderma sprucei, and Pseudofavolus miquelii. Comments about the species and illustrations are provided. Key words — mycodiversity, Agaricomycetes, Dacrymycetes Introduction Among the estimated 1.5 million fungal species, only 74,000 to 120,000 species have been described. With limited human and financial resources, a total inventory is not possible within any reasonable time frame, which is estimated to be 1290 years at the current rate (Garibay-Orijel et al. 2009). Within the field of mycology, there are numerous studies about the diversity of macrofungi. However, Gilbert & Souza (2002) and Piepenbring (2007) point out that a significant portion of the fungal taxa from tropical forests has not yet been described. In the southern region of coastal South America, the Atlantic Forest is broadly defined and includes not only coastal rain forests but also inland forests and coastal seasonal forests, which are mostly semi-deciduous and mixed Araucaria forests (Fernandes & Bezerra 1990). Knowledge about the abundance of lignolytic basidiomycetes in all forest types, as well as the fact that they are the largely responsible for decaying wood in most ecosystems, is well established.
    [Show full text]
  • Complete References List
    Aanen, D. K. & T. W. Kuyper (1999). Intercompatibility tests in the Hebeloma crustuliniforme complex in northwestern Europe. Mycologia 91: 783-795. Aanen, D. K., T. W. Kuyper, T. Boekhout & R. F. Hoekstra (2000). Phylogenetic relationships in the genus Hebeloma based on ITS1 and 2 sequences, with special emphasis on the Hebeloma crustuliniforme complex. Mycologia 92: 269-281. Aanen, D. K. & T. W. Kuyper (2004). A comparison of the application of a biological and phenetic species concept in the Hebeloma crustuliniforme complex within a phylogenetic framework. Persoonia 18: 285-316. Abbott, S. O. & Currah, R. S. (1997). The Helvellaceae: Systematic revision and occurrence in northern and northwestern North America. Mycotaxon 62: 1-125. Abesha, E., G. Caetano-Anollés & K. Høiland (2003). Population genetics and spatial structure of the fairy ring fungus Marasmius oreades in a Norwegian sand dune ecosystem. Mycologia 95: 1021-1031. Abraham, S. P. & A. R. Loeblich III (1995). Gymnopilus palmicola a lignicolous Basidiomycete, growing on the adventitious roots of the palm sabal palmetto in Texas. Principes 39: 84-88. Abrar, S., S. Swapna & M. Krishnappa (2012). Development and morphology of Lysurus cruciatus--an addition to the Indian mycobiota. Mycotaxon 122: 217-282. Accioly, T., R. H. S. F. Cruz, N. M. Assis, N. K. Ishikawa, K. Hosaka, M. P. Martín & I. G. Baseia (2018). Amazonian bird's nest fungi (Basidiomycota): Current knowledge and novelties on Cyathus species. Mycoscience 59: 331-342. Acharya, K., P. Pradhan, N. Chakraborty, A. K. Dutta, S. Saha, S. Sarkar & S. Giri (2010). Two species of Lysurus Fr.: addition to the macrofungi of West Bengal.
    [Show full text]